In the ceRNA network, PTGS2 was regulated by miR-148a-3p, and high expression of miR-148a-3p was significantly associated with increased OS in HNSCC patients (P = 0.0296; Figure 4). This evidence concerns the gene PTGS2 and head and neck squamous cell carcinoma.